These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30188760)

  • 1. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.
    Regev-Yochay G; Chowers M; Chazan B; Gonzalez E; Gray S; Zhang Z; Pride M
    Hum Vaccin Immunother; 2018; 14(10):2527-2532. PubMed ID: 30188760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
    Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
    J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.
    Forstner C; Kolditz M; Kesselmeier M; Ewig S; Rohde G; Barten-Neiner G; Rupp J; Witzenrath M; Welte T; Pletz MW;
    Vaccine; 2020 Jan; 38(5):1129-1136. PubMed ID: 31761500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.
    Isturiz RE; Ramirez J; Self WH; Grijalva CG; Counselman FL; Volturo G; Ostrosky-Zeichner L; Peyrani P; Wunderink RG; Sherwin R; Overcash JS; Oliva SP; File T; Wiemken TL; McLaughlin JM; Pride MW; Gray S; Alexander R; Ford KD; Jiang Q; Jodar L
    Vaccine; 2019 May; 37(25):3352-3361. PubMed ID: 31072732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2010 to 2012.
    Harat R; Alexander R; Gray S; Gutterman EM; Pluta J; Pride M; Shite S; Fijolek J; Kozub J
    Pneumonol Alergol Pol; 2016; 84(2):95-103. PubMed ID: 27238167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019.
    Liapikou A; Konstantinidis A; Kossyvaki V; Skiadas J; Menegas D; Méndez C; Beavon R; Begier E; Gessner BD; Milionis H; Tsimihodimos V; Baxevanos G; Argiriadou T; Terrovitou C; Toumbis M;
    Hum Vaccin Immunother; 2022 Nov; 18(5):2079923. PubMed ID: 35703733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.
    Self WH; Johnson KD; Resser JJ; Whitney CG; Baughman A; Kio M; Grijalva CG; Traenkner J; Johnson J; Miller KF; Rostad CA; Yildirim I; Salazar L; Tanios R; Swan SA; Zhu Y; Han JH; Weiss T; Roberts C; Rouphael N;
    Clin Infect Dis; 2024 Oct; 79(4):838-847. PubMed ID: 39016606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups.
    Daniel P; Rodrigo C; Bewick T; Sheppard C; Greenwood S; McKeever TM; Trotter C; Lim WS
    Vaccine; 2018 Mar; 36(12):1614-1620. PubMed ID: 29439865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Li L; Ambrose A; Hatchette TF; Lang AL; Gillis H; Martin I; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy A; McGeer A; Moraca S; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; McNeil SA;
    Vaccine; 2017 Jun; 35(29):3647-3654. PubMed ID: 28554501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.
    Duarte FG; Barberino MG; da Silva Moreira S; Reis JN; Spinardi JR; de Almeida RS; Allen KE; Alexander-Parrish R; Brim R; de Araújo Neto CA; Moreira ED
    BMJ Open; 2022 Apr; 12(4):e059824. PubMed ID: 35428648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
    Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
    Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Isturiz R; Grant L; Gray S; Alexander-Parrish R; Jiang Q; Jodar L; Peyrani P; Ford KD; Pride MW; Self WH; Counselman F; Volturo G; Ostrosky-Zeichner L; Wunderink RG; Sherwin R; Overcash JS; File T; Ramirez J
    Clin Infect Dis; 2021 Oct; 73(7):1216-1222. PubMed ID: 33982098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
    Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
    Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.
    Menéndez R; España PP; Pérez-Trallero E; Uranga A; Méndez R; Cilloniz C; Marimón JM; Cifuentes I; Méndez C; Torres A
    Vaccine; 2017 Sep; 35(39):5264-5270. PubMed ID: 28823622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
    Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy.
    Esposito S; Marchese A; Tozzi AE; Rossi GA; Da Dalt L; Bona G; Pelucchi C; Schito GC; Principi N;
    Pediatr Infect Dis J; 2012 Jul; 31(7):705-10. PubMed ID: 22426300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    McLaughlin JM; Jiang Q; Isturiz RE; Sings HL; Swerdlow DL; Gessner BD; Carrico RM; Peyrani P; Wiemken TL; Mattingly WA; Ramirez JA; Jodar L
    Clin Infect Dis; 2018 Oct; 67(10):1498-1506. PubMed ID: 29790925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia.
    Grant LR; Begier E; Theilacker C; Barry R; Hall-Murray C; Yan Q; Pope V; Pride MW; Jodar L; Gessner BD
    J Infect Dis; 2024 Jan; 229(1):282-293. PubMed ID: 37665210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions.
    Hyun H; Jang AY; Suh JW; Bae IG; Choi WS; Seo YB; Lee J; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Kim MJ; Song JY
    J Korean Med Sci; 2023 Oct; 38(42):e330. PubMed ID: 37904655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.